Inhibikase Therapeutics Inc. (IKT)
NASDAQ · Healthcare
Inhibikase Therapeutics Inc. Cash Flow 2020–2024
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -27.8M | -19.1M | -18.1M | -17.4M | -14.3M | -1.1M |
| Depreciation & Amort. | — | — | — | — | — | — |
| Investing Activities | ||||||
| Capital Expenditure | 13,399 | 0 | 14,238 | 243,255 | 0 | — |
| Free Cash Flow | -27.8M | -19.1M | -18.1M | -17.6M | -14.3M | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
Inhibikase Therapeutics Inc. Cash Flow — FAQ
Inhibikase Therapeutics Inc. (IKT) cash flow over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IKT's cash flow history?
The chart and table above show Inhibikase Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.